Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Line Management”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)UnknownNCT06304025
What this trial is testing

Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment

Who this might be right for
Graft Versus Host Disease
Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle 10
Post-approval studies (Phase 4)Study completedNCT00558077
What this trial is testing

Second-Line Treatments for Anovulatory Infertility in PCOS Patients

Who this might be right for
Polycystic Ovary SyndromeInfertilityAnovulation
University Magna Graecia 50
Testing effectiveness (Phase 2)Study completedNCT00252382
What this trial is testing

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Sunesis Pharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT01379534
What this trial is testing

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Who this might be right for
Solid Tumors and Advanced Endometrial CancerEndometrial CancerSecond-line Treatment+1 more
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT03517800
What this trial is testing

Surgical Management of Postpartum Haemorrhage Without Embolization

Who this might be right for
Postpartum HemorrhageSecond Line ManagementUterine Arteries Embolization+1 more
University Hospital, Montpellier 716
Testing effectiveness (Phase 2)Study completedNCT00034164
What this trial is testing

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Achieve Life Sciences 52
Testing effectiveness (Phase 2)Study completedNCT00919451
What this trial is testing

Ciclosporin in the Management of Steroid Resistant Type 1 Reactions in Leprosy

Who this might be right for
Leprosy
London School of Hygiene and Tropical Medicine 16
Not applicableStudy completedNCT00050089
What this trial is testing

CSP #512 - Options in Management With Anti-Retrovirals

Who this might be right for
AIDSHIV Infections
US Department of Veterans Affairs 368
Early research (Phase 1)Study completedNCT02128308
What this trial is testing

Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents

Who this might be right for
Healthy
Seoul National University Hospital 16
Not applicableStudy completedNCT05444933
What this trial is testing

Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

Who this might be right for
Advanced Renal Cell Carcinoma
Ipsen 252
Testing effectiveness (Phase 2)Study completedNCT00034190
What this trial is testing

Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma

Who this might be right for
Colorectal Adenocarcinoma
Achieve Life Sciences 28
Not applicableLooking for participantsNCT04030507
What this trial is testing

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer+3 more
Brigham and Women's Hospital 214
Testing effectiveness (Phase 2)Ended earlyNCT00755118
What this trial is testing

Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

Who this might be right for
Colorectal Cancer
University Hospital of Crete 24
Testing effectiveness (Phase 2)UnknownNCT04656002
What this trial is testing

As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers

Who this might be right for
Gastric Cancer
Samsung Medical Center 43
Testing effectiveness (Phase 2)Study completedNCT03801304
What this trial is testing

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital, Brest 80
Testing effectiveness (Phase 2)WithdrawnNCT00209612
What this trial is testing

Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.

Who this might be right for
Gastric Cancer
Hokkaido Gastrointestinal Cancer Study Group 40
Testing effectiveness (Phase 2)Study completedNCT01576380
What this trial is testing

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Who this might be right for
Adenocarcinoma, ScirrhousLinitis PlasticaStomach Neoplasms+3 more
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Study completedNCT00034177
What this trial is testing

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Who this might be right for
Urologic Neoplasms
Achieve Life Sciences 27